Continuation Strategy

You should seriously consider filing a continuation application in three situations: (1) Before making a narrowing amendment in the parent — file the continuation before you respond to the first or subsequent Office Action with a claim amendment. This gives the continuation a clean prosecution history, unencumbered by the Festo estoppel that will attach to the parent's amended claims. You preserve the right to pursue the broader scope in the continuation without the estoppel created by the parent's prosecution. (2) Before the parent issues — every patent application should be evaluated for whether a continuation should be filed before the patent issues. Once the parent issues, the application is closed and no further continuations can claim its benefit. For commercially significant patents, the answer is almost always to file at least one continuation. The continuation keeps you in the game: you can pursue new claim language to cover competitor products, target design-arounds that emerge post-grant, or simply have a pending application available to produce in response to competitive threats. (3) After a granted patent, when you discover a design-around — when a competitor avoids your granted claims by changing a feature, you can file a continuation (if a pending ancestor exists) with claims written to cover the design-around. The continuation inherits the parent's priority date, so the competitor's product (which didn't exist at the parent's priority date) is not prior art to the continuation claims. The practical result is that continuation practice lets your patent portfolio 'evolve' to match the actual competitive landscape rather than being frozen at the claim language written before any commercial products existed.

A continuation (CON) and a continuation-in-part (CIP) are both types of continuing applications under 35 U.S.C. § 120, but they differ in one critical way: whether they add new technical content. Continuation (CON): uses the IDENTICAL specification as the parent application (no new matter); all claims must be supported by the original specification; all claims inherit the parent's full priority date. This is appropriate when you want to pursue different claims on the same invention disclosure — for example, broader claims, or method claims when the parent covered only apparatus claims, or claims tailored to cover a specific competitor product. Continuation-in-Part (CIP): ADDS new technical content beyond the parent's specification; claims supported by the parent specification still get the parent's priority date; claims supported only by the new matter added to the CIP specification get the CIP's own filing date — NOT the parent's date. The new filing date for new-matter claims creates a risk: any prior art that emerged between the parent's filing date and the CIP's filing date can be used against those new-matter claims. This includes publications by the inventors themselves. A CIP is appropriate only when you genuinely need to incorporate new developments that weren't in the parent. For most situations, a continuation (which uses the identical specification) is simpler, cheaper, and better — it avoids the complicated priority analysis required for CIP claims and avoids the risk that new-matter claims get a later priority date. A common mistake: filing a CIP when a CON would do. If the new claims can be fully supported by the original parent specification, file a continuation, not a CIP.

Yes — a continuation application can pursue claims that are broader than the claims granted in the parent patent, subject to two constraints: the double patenting rules, and the specification's disclosure. Double patenting: a continuation cannot claim subject matter that is patentably indistinct from the parent's granted claims (obviousness-type double patenting, or ODP). If the continuation's claims are obvious over the parent's granted claims, a terminal disclaimer (tying the continuation's expiration date to the parent's expiration date) is required to overcome the rejection. However, the continuation CAN claim scope that goes beyond the parent — it can claim subject matter that is distinct enough not to be obvious over the parent's claims, or it can claim in a different statutory class (e.g., a method claim when the parent claimed an apparatus). Specification support: the broader claims must be supported by the parent's specification under § 112(a) — the specification must enable a person skilled in the art to make and use the full scope claimed, and must provide adequate written description. After Amgen v. Sanofi (S.Ct. 2023), functional genus claims that go far beyond the examples in the specification are at significant enablement risk. A common strategy: narrow the parent's independent claims to get them allowed quickly (securing a priority date, establishing a patent, and creating prior art against competitors), then file a continuation pursuing the broader scope. The continuation benefits from the same priority date as the parent, and the parent's narrow claims don't constitute prior art against the continuation (35 U.S.C. § 120 creating a related application, not the § 102 prior art provisions).

Prosecution history estoppel under Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co. (S.Ct. 2002) presents a nuanced challenge in continuation families. The core principle: when a patent applicant narrows a claim by amendment to overcome a prior art rejection (§ 102 or § 103), the applicant is presumed to have surrendered all scope between the original and the amended claim — the doctrine of equivalents (DOE) cannot recover that surrendered territory. The effect across a continuation family depends on when the continuation was filed relative to the limiting amendment: (1) Continuation filed BEFORE the limiting amendment: the continuation's prosecution history does not include the limiting amendment. The continuation can argue broader scope — including equivalents — without the Festo estoppel that applies to the parent's claims. This is the key reason to file continuations BEFORE responding to Office Actions with narrowing amendments. (2) Continuation filed AFTER the limiting amendment: in this case, the continuation inherits the same specification but starts fresh prosecution — it does NOT automatically inherit the parent's prosecution history estoppel. However, if the continuation's claims include the same limitation that was amended in the parent, a court might consider the parent's prosecution history as relevant context for claim construction, even if it doesn't create binding estoppel on the continuation. (3) Continuation with claims in a DIFFERENT claim class: if the parent's method claim was amended to add a limitation, and the continuation pursues apparatus claims that do not include that limitation, the estoppel from the parent's method claim does not apply to the continuation's apparatus claims (different claim limitations). Bottom line: file continuations before making limiting amendments in the parent to maximize DOE scope and minimize estoppel risk across the family.

A patent family blocking strategy uses multiple related applications — continuations, divisionals, and CIPs sharing the same priority date — to build overlapping coverage that makes it difficult for a competitor to design around the portfolio. The goal is not just to get one patent granted, but to have claims at multiple levels of scope and in multiple statutory classes, so that avoiding any one claim exposes the competitor to another. Key elements of a blocking strategy: (1) Scope laddering: independent claims at multiple levels of breadth. Broad independent claims (genus level) protect the core inventive concept. Intermediate claims protect important commercial embodiments. Narrow claims protect the specific product or process. If an IPR invalidates the broad claims, the intermediate and narrow claims may survive. If a competitor designs around the narrow claims, the broad claims still cover the design-around. (2) Multiple statutory classes: method claims + apparatus claims + system claims covering different actors. Method claims can catch end users or service providers. Apparatus claims catch manufacturers. System claims catch integrators. A competitor who avoids infringement of the apparatus claim by making only a component may still infringe the system claim. (3) Keep a pending application: at least one continuation or divisional application should remain pending in every commercially important family. A pending application is invaluable: it can be amended to cover newly discovered competitor products, it creates leverage in licensing negotiations, and it deters competitors from entering the space. (4) Design-around-resistant claims: analyze the most likely design-around paths (what component or step is a competitor most likely to modify to avoid literal infringement?) and write continuation claims that cover those alternatives. (5) International coordination: coordinate the US continuation family with PCT claims and national-phase prosecution to build a consistent blocking strategy in key markets (US, EP, JP, KR, CN). The prosecution history in each jurisdiction is independent — estoppel from US prosecution does not directly create estoppel in EP prosecution. Patent families built by companies like Qualcomm (wireless), IBM (computing), and the major pharma companies exemplify this strategy — their portfolios have hundreds of related patents creating a dense web of overlapping coverage that makes design-arounds economically unattractive.